A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Type of Cancer
Solid Tumor

Sponsor
Moderna

Protocol Number
mRNA-4157-P101

To Learn More Call
201-510-0910